The U.S. Food and Drug Administration (FDA) has certified Fibonacci Corporation, and the company is now successfully registered.
We believe it is essential to add value to the industry and push the boundaries of science, technology and health. In this sense, opening markets means acting wisely and taking healthcare needs into account to create integrated value chains. We are committed to promoting new commercial agreements focused on improving our productivity, competitiveness, and foreign trade.
Our company provides models of technology systems and devices for automating the medicine of the future and we are engaged in improving lives through technical solutions and management processes for the healthcare market. Although we currently operate in Latin America and the Caribbean, this registration will allow us to expand into the highly competitive North American market, where the dynamism of the environment demands that we continuously optimize our processes.
Having obtained operator No. 10084564 and the FDA certification that you can see here constitutes an achievement for our technological DNA.
The U.S. Food and Drug Administration (FDA) examines, evaluates, and approves a wide range of medical products, including drugs, medical devices, food, cosmetics and many other health-related products, to ensure their efficacy, quality and safety. In this regard, we are pleased and proud to offer technological solutions and many of the world’s best-selling products destined to improve patients’ quality of life and support the healthcare industry.